Ingensity IP
Ingensity IP specializes in designing IP strategies for biotech and life science technologies. They provide strategic intellectual property solutions, fitness assessments, and planning to help companies grow and strengthen their IP portfolios. Their mission is to support life sciences companies and investors by translating IP landscape information into actionable steps to enhance competitive positioning and align IP strategies with business goals.
Industries
Nr. of Employees
small (1-50)
Services
Ongoing strategic IP advisory delivered through a fixed-fee monthly subscription, including alignment of IP with business and product timelines and on-call support via client portals.
Comprehensive review of patent portfolios and recommendations to address coverage gaps, protect product features and methods, and prepare for financing or partnerships.
Market and patent landscape studies to map competitor activity, assess differentiation, and inform strategic product direction.
Development of patent filing plans, claim drafting, and support for prosecution in the US and international jurisdictions.
Analyses of third-party patent rights to determine risk to product development and recommendations for mitigation.
Pre-diligence and due diligence assessments for financing, acquisitions, licensing, and IPO preparation focused on IP strengths, weaknesses, and third-party exposure.
Ongoing strategic IP advisory delivered through a fixed-fee monthly subscription, including alignment of IP with business and product timelines and on-call support via client portals.
Comprehensive review of patent portfolios and recommendations to address coverage gaps, protect product features and methods, and prepare for financing or partnerships.
Market and patent landscape studies to map competitor activity, assess differentiation, and inform strategic product direction.
Development of patent filing plans, claim drafting, and support for prosecution in the US and international jurisdictions.
Analyses of third-party patent rights to determine risk to product development and recommendations for mitigation.
Pre-diligence and due diligence assessments for financing, acquisitions, licensing, and IPO preparation focused on IP strengths, weaknesses, and third-party exposure.
Expertise Areas
- IP strategy for biotech and life sciences
- IP portfolio assessment and planning
- Patent prosecution and claim drafting
- Freedom-to-operate and third-party IP analysis
Key Technologies
- Patent landscape mapping
- Freedom-to-operate analysis
- Patent drafting and prosecution
- IP portfolio analytics
News & Updates
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Cras ultricies ligula sed magna dictum porta.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Cras ultricies ligula sed magna dictum porta.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Cras ultricies ligula sed magna dictum porta.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Cras ultricies ligula sed magna dictum porta.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Cras ultricies ligula sed magna dictum porta.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Cras ultricies ligula sed magna dictum porta.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Cras ultricies ligula sed magna dictum porta.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Cras ultricies ligula sed magna dictum porta.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Cras ultricies ligula sed magna dictum porta.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Cras ultricies ligula sed magna dictum porta.